
Solasta Ventures
Description
Solasta Ventures is a global venture capital firm dedicated to investing in the healthcare and life sciences sectors. Founded in 2020, the firm is headquartered in Boston, Massachusetts, and focuses on identifying and supporting innovative companies that are poised to transform patient outcomes and advance medical frontiers. With a strong emphasis on deep domain expertise, Solasta Ventures backs entrepreneurs and management teams with the potential to build enduring businesses.
The firm's investment strategy spans early to growth-stage companies, targeting opportunities across a broad spectrum of healthcare sub-sectors. These include biotechnology, medical devices, digital health solutions, and healthcare services. Solasta Ventures seeks to partner with its portfolio companies, leveraging its team's extensive operational and investment experience to provide strategic guidance beyond just capital. Their approach is characterized by a commitment to fostering long-term value creation within the complex and rapidly evolving healthcare landscape.
Solasta Ventures manages a $100 million fund, which underpins its investment activities. Since its inception, the firm has actively deployed capital, making approximately 15 investments in promising healthcare ventures. While specific check sizes can vary based on the stage and needs of the company, Solasta Ventures typically provides initial investments ranging from $2 million to $10 million. This range allows them to support companies from their foundational stages through significant growth milestones, reinforcing their mission to contribute to a brighter future in healthcare.
Investor Profile
Solasta Ventures has backed more than 31 startups, with 2 new investments in the last 12 months alone. The firm has led 1 rounds, about 3% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, New Zealand, Canada.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Typical check size: $2M – $10M.
Stage Focus
- Series B (39%)
- Series C (19%)
- Series A (16%)
- Series Unknown (10%)
- Post Ipo Equity (10%)
- Series D (6%)
Country Focus
- United States (90%)
- New Zealand (3%)
- Canada (3%)
- United Kingdom (3%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Life Science
- Oncology
- Biopharma
- Pharmaceutical
- Genetics
- Software
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.